323 related articles for article (PubMed ID: 9825476)
1. Definition of the role of somatostatin receptor scintigraphy in gastrointestinal neuroendocrine tumor localization.
Jensen RT; Gibril F; Termanini B
Yale J Biol Med; 1997; 70(5-6):481-500. PubMed ID: 9825476
[TBL] [Abstract][Full Text] [Related]
2. Comparative analysis of diagnostic techniques for localization of gastrointestinal neuroendocrine tumors.
Gibril F; Jensen RT
Yale J Biol Med; 1997; 70(5-6):509-22. PubMed ID: 9825478
[TBL] [Abstract][Full Text] [Related]
3. Somatostatin receptor scintigraphy in gastrinomas.
Jensen RT; Gibril F
Ital J Gastroenterol Hepatol; 1999 Oct; 31 Suppl 2():S179-85. PubMed ID: 10604126
[TBL] [Abstract][Full Text] [Related]
4. Bone metastases in patients with gastrinomas: a prospective study of bone scanning, somatostatin receptor scanning, and magnetic resonance image in their detection, frequency, location, and effect of their detection on management.
Gibril F; Doppman JL; Reynolds JC; Chen CC; Sutliff VE; Yu F; Serrano J; Venzon DJ; Jensen RT
J Clin Oncol; 1998 Mar; 16(3):1040-53. PubMed ID: 9508189
[TBL] [Abstract][Full Text] [Related]
5. Distinguishing small hepatic hemangiomas from vascular liver metastases in gastrinoma: use of a somatostatin-receptor scintigraphic agent.
Termanini B; Gibril F; Doppman JL; Reynolds JC; Stewart CA; Sutliff VE; Venzon DJ; Jensen RT
Radiology; 1997 Jan; 202(1):151-8. PubMed ID: 8988205
[TBL] [Abstract][Full Text] [Related]
6. Somatostatin receptor scintigraphy in liver metastasis detection from gastroenteropancreatic neuroendocrine tumors.
Schillaci O; Spanu A; Scopinaro F; Falchi A; Danieli R; Marongiu P; Pisu N; Madeddu G; Delle Fave G; Madeddu G
J Nucl Med; 2003 Mar; 44(3):359-68. PubMed ID: 12621001
[TBL] [Abstract][Full Text] [Related]
7. Clinical impact of somatostatin receptor scintigraphy in the management of patients with neuroendocrine gastroenteropancreatic tumors.
Lebtahi R; Cadiot G; Sarda L; Daou D; Faraggi M; Petegnief Y; Mignon M; le Guludec D
J Nucl Med; 1997 Jun; 38(6):853-8. PubMed ID: 9189129
[TBL] [Abstract][Full Text] [Related]
8. Specificity of somatostatin receptor scintigraphy: a prospective study and effects of false-positive localizations on management in patients with gastrinomas.
Gibril F; Reynolds JC; Chen CC; Yu F; Goebel SU; Serrano J; Doppman JL; Jensen RT
J Nucl Med; 1999 Apr; 40(4):539-53. PubMed ID: 10210211
[TBL] [Abstract][Full Text] [Related]
9. Somatostatin receptor scintigraphy: its sensitivity compared with that of other imaging methods in detecting primary and metastatic gastrinomas. A prospective study.
Gibril F; Reynolds JC; Doppman JL; Chen CC; Venzon DJ; Termanini B; Weber HC; Stewart CA; Jensen RT
Ann Intern Med; 1996 Jul; 125(1):26-34. PubMed ID: 8644985
[TBL] [Abstract][Full Text] [Related]
10. Value of somatostatin receptor scintigraphy: a prospective study in gastrinoma of its effect on clinical management.
Termanini B; Gibril F; Reynolds JC; Doppman JL; Chen CC; Stewart CA; Sutliff VE; Jensen RT
Gastroenterology; 1997 Feb; 112(2):335-47. PubMed ID: 9024287
[TBL] [Abstract][Full Text] [Related]
11. Prospective study of somatostatin receptor scintigraphy and its effect on operative outcome in patients with Zollinger-Ellison syndrome.
Alexander HR; Fraker DL; Norton JA; Bartlett DL; Tio L; Benjamin SB; Doppman JL; Goebel SU; Serrano J; Gibril F; Jensen RT
Ann Surg; 1998 Aug; 228(2):228-38. PubMed ID: 9712569
[TBL] [Abstract][Full Text] [Related]
12. The value of somatostatin-receptor scintigraphy in newly diagnosed endocrine gastroenteropancreatic tumors.
Kisker O; Bartsch D; Weinel RJ; Joseph K; Welcke UH; Zaraca F; Rothmund M
J Am Coll Surg; 1997 May; 184(5):487-92. PubMed ID: 9145069
[TBL] [Abstract][Full Text] [Related]
13. Somatostatin receptor scintigraphy versus chromogranin A assay in the management of patients with neuroendocrine tumors of different types: clinical role.
Cimitan M; Buonadonna A; Cannizzaro R; Canzonieri V; Borsatti E; Ruffo R; De Apollonia L
Ann Oncol; 2003 Jul; 14(7):1135-41. PubMed ID: 12853358
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of somatostatin receptor scintigraphy in patients with occult ectopic adrenocorticotropin syndrome.
Tabarin A; Valli N; Chanson P; Bachelot Y; Rohmer V; Bex-Bachellerie V; Catargi B; Roger P; Laurent F
J Clin Endocrinol Metab; 1999 Apr; 84(4):1193-202. PubMed ID: 10199752
[TBL] [Abstract][Full Text] [Related]
15. [Pre- and intraoperative localization of neuroendocrine tumors].
Adams S; Baum RP; Adams M; Wenisch H; Schumm-Draeger PM; Encke A; Usadel KH; Hör G
Acta Med Austriaca; 1997; 24(2):81-6. PubMed ID: 9273812
[TBL] [Abstract][Full Text] [Related]
16. Somatostatin receptor imaging with indium-111-pentetreotide in gastroenteropancreatic neuroendocrine tumors: safety, efficacy and impact on patient management.
Jamar F; Fiasse R; Leners N; Pauwels S
J Nucl Med; 1995 Apr; 36(4):542-9. PubMed ID: 7699439
[TBL] [Abstract][Full Text] [Related]
17. Imaging of neuroendocrine tumors: accuracy of helical CT versus SRS.
Kumbasar B; Kamel IR; Tekes A; Eng J; Fishman EK; Wahl RL
Abdom Imaging; 2004; 29(6):696-702. PubMed ID: 15162235
[TBL] [Abstract][Full Text] [Related]
18. Influence of somatostatin receptor scintigraphy and CT/MRI on the clinical management of patients with gastrointestinal neuroendocrine tumors: an analysis in 188 patients.
Gotthardt M; Dirkmorfeld LM; Wied MU; Rinke A; Béhé MP; Schlieck A; Höffken H; Alfke H; Joseph K; Klose KJ; Behr TM; Arnold R
Digestion; 2003; 68(2-3):80-5. PubMed ID: 14581764
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness analysis of somatostatin receptor scintigraphy.
Kwekkeboom DJ; Lamberts SW; Habbema JD; Krenning EP
J Nucl Med; 1996 Jun; 37(6):886-92. PubMed ID: 8683305
[TBL] [Abstract][Full Text] [Related]
20. Endoscopic ultrasonography of neuroendocrine tumours.
Zimmer T; Scherübl H; Faiss S; Stölzel U; Riecken EO; Wiedenmann B
Digestion; 2000; 62 Suppl 1():45-50. PubMed ID: 10940687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
